OpenHysterectomy near West Harrison, NY

Biography: Tracy Bohn Hemmerdinger, MD, is the medical director of obstetrics and gynecology (OB-GYN) at NewYork-Presbyterian Medical Group Hudson Valley and division chief of obstetrics and gynecology at NewYork-Presbyterian Hudson Valley Hospital. She is an assistant professor of obstetrics and gynecology at Columbia University Medical Center. In her role, Dr. Hemmerdinger will continue to expand NewYork-Presbyterian Hudson Valley Hospital's obstetrics and gynecology division through provider recruitment and community outreach. In January 2021, the hospital opened its newly renovated Maternal & Newborn Care Unit, designed to provide an outstanding experience before, during and after childbirth and expand access to the hospital's team of leading specialists and expert care. Dr. Hemmerdinger is a board-certified OB-GYN and has been a fellow of the American College of Obstetrics and Gynecology since 2008. She also served as a member of the NYC Health + Hospitals/Elmhurst Blood Utilization Committee. An accomplished academic researcher, Dr. Hemmerdinger has published in peer-reviewed journals, most recently on the topic of universal screening for SARS-CoV-2 infection among pregnant women. The recipient of multiple awards and honors, Dr. Hemmerdinger has been awarded the NYC Health + Hospitals/Elmhurst's Elmmy Award, honoring exceptional service and care to patients. Passionate about training physicians, she also received the 2014-2015 Medical Student Teaching Award for outstanding teacher of obstetrics and gynecology from the Icahn School of Medicine at Mount Sinai, as selected by the medical students. After graduating from Icahn School of Medicine at Mount Sinai, Dr. Hemmerdinger served her residency At Mount Sinai Medical Center. She has served as a resident mentor from 2010-2020, before becoming a resident family mentor from 2020-2021.

Biography: James McKiernan, MD, is the John K. Lattimer Professor of Urology, and CEO, of ColumbiaDoctors. He also is the interim dean of Columbia University Vagelos College of Physicians and Surgeons. Dr. McKiernan graduated from Johns Hopkins University with a BA in biology and received his MD from Columbia University College of Physicians and Surgeons. He completed his training in urology and general surgery at NewYork-Presbyterian Hospital, followed by a urologic surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center. Dr. McKiernan's clinical practice is focused on urologic oncology and particularly on surgical therapy in high-risk patients with bladder and kidney cancers. Dr. McKiernan evaluates and treats over 1,000 patients with bladder cancer every year. His research, funded by NIH and biotechnology industry grants, focuses on developing novel therapeutics for bladder cancer treatment as well as comparative effectiveness research in urologic oncology. In the management of kidney and bladder cancer, he has special expertise in organ preservation and reconstructive surgery to maximize quality of life. Dr. McKiernan's research has been published in Cancer, Cancer Research, the Journal of Clinical Oncology, JAMA Oncology, Journal of Urology, Urologic Oncology, and Urology. He has authored and co-authored more than 220 scientific articles and book chapters on urologic cancer and related issues. For the past 10 years, he has directed a research team at Columbia University Medical Center investigating quality outcomes and effectiveness in urologic cancer surgery. He has served as the Vice Chairman for the AJCC TNM Staging Task Force, Co-Chair of the AUA Guidelines Panel on non-muscle invasive bladder cancer, as well as on the American Board of Urology and Society of Urologic Oncology Examination Committees. In addition, Dr. McKiernan is the principal investigator of the NIH-funded clinical trials program of experimental therapeutics in bladder cancer at Columbia University/NYPH, which is investigating new agents for bladder preservation in patients whose cancer has recurred after standard therapy. In collaboration with researchers at Columbia's Herbert Irving Comprehensive Cancer Center, his team continues to develop new therapeutic strategies for managing bladder cancer.

Care Philosophy: We are committed to delivering the best care and an exceptional patient experience. We are devoted to providing services that are patient-centered and compassionate, and care for you as a person.